Opaleye Management Inc. 13D and 13G filings for Protara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-28 4:05 pm Sale | 2025-03-31 | 13G | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 1,730,000 4.710% | -95,000 (-5.21%) | Filing |
| 2025-02-14 06:31 am Purchase | 2024-12-31 | 13G | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 1,825,000 5.320% | 143,846 (+8.56%) | Filing |
| 2024-11-18 06:01 am Purchase | 2024-09-30 | 13G | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 1,681,154 8.150% | 1,681,154 (New Position) | Filing |